Key Insights

Highlights

Treatment Research

1 treatments under study, led by Pausing Oral Contraceptive

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Unknown1

Clinical Trials (1)

Research Network

Common Treatments

  • Pausing Oral Contraceptive1

Active Sponsors

  • Anders Nyboe Andersen1
  • Herlev Hospital1
  • Hvidovre University Hospital1

Top Investigators

Related Conditions

  • Amh1
  • Oral Contraceptives1
  • Longterm Use1

Activity Timeline